Vimarsana
Biggest News Aggregation in the World

Page 22 - High Throughput Screening News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from High Throughput Screening. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In High Throughput Screening Today - Breaking & Trending Today

Researchers identify SARS-CoV-2 antiviral compounds using protein assay - Vimarsana News

Researchers identify SARS-CoV-2 antiviral compounds using protein assay

During the process of SARS-CoV-2 infection, once the virus penetrates the host cell, two open reading frames, ORF1a and ORF1ab, are translated. ORF1ab is responsible for the production of 16 nonstructural proteins (nsp). Several viral proteases such as 3CLpro and PLpro (papain-like protease) produce 1-16 nsps. A new study has been published in bioRxiv* preprint server, which deals with identifying drugs that are effective as PLpro inhibitors.

Worldwide Liquid Handling System Industry to 2025 - Increasing Research Activities in Genomics and Proteomics Presents Opportunities - Vimarsana News

Worldwide Liquid Handling System Industry to 2025 - Increasing Research Activities in Genomics and Proteomics Presents Opportunities

Share this article Share this article ResearchAndMarkets.com's offering. The Global Liquid Handling System Market is estimated to be USD 3.3 Bn in 2020 and is expected to reach USD 4.65 Bn by 2025, growing at a CAGR of 7.1%. Market Dynamics Major factors that drive the market growth are increasing expenditure in research & development activities, growing technological advancements, the need for new drug development, and the growing demand for high-output screening. All these help in driving the market growth of the Global Liquid Handling System Market. In addition to this, rapid adoption of ...

Researchers discover SARS-CoV-2 inhibitors - Vimarsana News

Researchers discover SARS-CoV-2 inhibitors

 E-Mail IMAGE: with one of the newly developed inhibitors in the active centre. The individual domains of the protein are shown in different colours, the inhibitor in pink. view more  Credit: © V. Namasivayam/Pharmazeutisches Institut/Uni Bonn A research team of pharmacists at the University of Bonn has discovered two families of active substances that can block the replication of the SARS-CoV-2 coronavirus. The drug candidates are able to switch off the the key enzyme of the virus, the so-called main protease. The study is based on laboratory experiments. Extensive clinical trials...

Pharmacists discover active substances that block SARS-CoV-2 replication - Vimarsana News

Pharmacists discover active substances that block SARS-CoV-2 replication

A research team of pharmacists at the University of Bonn has discovered two families of active substances that can block the replication of the SARS-CoV-2 coronavirus. The drug candidates are able to switch off the the key enzyme of the virus, the so-called main protease.

Biological activity-based modeling offers a new approach for drug discovery - Vimarsana News

Biological activity-based modeling offers a new approach for drug discovery

Biological activity-based modeling offers a new approach for drug discovery Assessing a drug compound by its activity, not simply its structure, is a new approach that could speed the search for COVID-19 therapies and reveal more potential therapies for other diseases. This action-based focus -- called biological activity-based modeling (BABM) -- forms the core of a new approach developed by the National Center for Advancing Translational Sciences (NCATS) researchers and others. NCATS is part of the National Institutes of Health (NIH). Researchers used BABM to look for potential anti-SARS-CoV...